Intellia Therapeutics, Inc. NTLA

Set alert

11.35 USD +0.25 (+2.25%)

At closeNov 6, 2026, 4:57 PM EST

11.36 +0.01 +0.09%

After hours · Nov 6, 4:57 PM ET

11.02 Day range 11.40

7.95 52-week range 18.48

Held by insiders 3.97%

Held by institutions 100.51%

Float held by institutions 104.67%

Institutions 431

Top institutional holders
Holder	% held	Shares	Value	Reported
ARK Investment Management, LLC	12.04%	16,875,684	191.54M	Jun 29, 2026
Blackrock Inc.	11.00%	15,409,023	174.89M	Jun 29, 2026
State Street Corporation	6.59%	9,234,987	104.82M	Jun 29, 2026
Vanguard Portfolio Management LLC	5.23%	7,332,401	83.22M	Jun 29, 2026
Shaw D.E. & Co., Inc.	4.60%	6,443,323	73.13M	Jun 29, 2026
Vanguard Capital Management LLC	4.30%	6,028,586	68.42M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
ARK ETF Trust-ARK Innovation ETF	7.40%	10,368,179	117.68M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	3.06%	4,286,200	48.65M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	3.06%	4,286,323	48.65M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.54%	3,564,714	40.46M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	2.22%	3,106,242	35.26M	Jun 29, 2026
ARK ETF Trust-ARK Genomic Revolution ETF	1.98%	2,781,291	31.57M	Sep 29, 2026

NTLA insiders
Insider	Relation	Latest transaction	Date	Shares held
BASTA JAMES EDMUND	General Counsel	Sale	Mar 1, 2026	156,794
CHASE WILLIAM J	Director	Stock Award(Grant)	Jun 8, 2026	143,893
CLARK ELIANA	Chief Technology Officer	Sale	Mar 1, 2026	93,864
COHEN FREDERICK E. M.D. PH.D.	Director	Stock Award(Grant)	Jun 8, 2026	216,653
DULAC EDWARD J III	Chief Financial Officer	Sale	Jul 21, 2026	148,175
LEBWOHL DAVID	Officer	Stock Award(Grant)	Feb 26, 2026	131,192

Held by funds